ADHD
86 results
1 - 86Meditation therapies for attention‐deficit/hyperactivity disorder (ADHD)
Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Cognitive‐behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults
Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents
Acupuncture for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents: Cochrane systematic review
Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents: Cochrane systematic review
Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years
Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults: Cochrane systematic review
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years: Cochrane systematic review
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies: Cochrane systematic review
Stimulant and non‐stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy
Risperidone for attention‐deficit hyperactivity disorder in people with intellectual disabilities
Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities
Family therapy for attention‐deficit disorder or attention‐deficit/hyperactivity disorder in children and adolescents
Pharmacological intervention for irritability, aggression, and self‐injury in autism spectrum disorder (ASD)
Methylphenidate for children and adolescents with autism spectrum disorder
Homeopathy for attention deficit/hyperactivity disorder or hyperkinetic disorder
Psychostimulant drugs for cocaine dependence
Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders
Pine bark (Pinus spp.) extract for treating chronic disorders
Statins for Smith‐Lemli‐Opitz syndrome
Memantine for autism spectrum disorder
Selective noradrenaline reuptake inhibitors for schizophrenia
Education support services for improving school engagement and academic performance of children and adolescents with a chronic health condition
Later school start times for supporting the education, health, and well‐being of high school students
New generation antidepressants for depression in children and adolescents: a network meta‐analysis
Atypical antipsychotics for disruptive behaviour disorders in children and youths
Sedation of children undergoing dental treatment
Pharmacological interventions for those who have sexually offended or are at risk of offending